|
Instranasal Delivery of Apilimod and Nafamostat for the Treatment of COVID
Intranasal Delivery of Apilimod and Nafamostat for the Treatment of COVID
Unmet Need
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused the coronavirus disease 2019 (COVID-19) pandemic and has profoundly impacted global human health. Since its initial discovery in 2019, several viral variants have caused additional outbreaks...
Published: 6/26/2025
|
Updated: 5/23/2023
|
Inventor(s): Tomas Kirchhausen, Alex Kreutzberger, Giuseppe Balistreti
Keywords(s): Combination Therapy, Drug Repurposing
Category(s): Technology Classifications > Invention Type, Technology Classifications > Invention Type > Therapeutics, Technology Classifications > Invention Type > Therapeutics > Small Molecule, Technology Classifications > Disease Area, Technology Classifications > Disease Area > Infectious Disease, Technology Classifications > Disease Area > Infectious Disease > COVID-19
|
